News Daily News Financial Strain Ups Risk of Death After Acute MI in the Elderly L.A. McKeown February 25, 2022
News Daily News Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis Michael O'Riordan February 18, 2022
News Daily News Robert M. Califf Becomes 25th Commissioner of the US FDA L.A. McKeown February 15, 2022
News Daily News Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension Caitlin E. Cox February 11, 2022
News Daily News Before and After PCI, Women Have Poorer Health Status Than Men L.A. McKeown January 28, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Daily News Yet Another US Report Shows Stalled Progress Against CHD Caitlin E. Cox January 19, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S Caitlin E. Cox January 07, 2022
News Daily News TCTMD’s Top 10 Most Popular Stories for December 2021 Caitlin E. Cox December 29, 2021
News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News Black Patients With Chest Pain Differ From Whites, but Risks Are Similar Michael O'Riordan December 23, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021